What were Balchem Corporation's Q2 2026 revenue and year-over-year growth rate, and which segment contributed most significantly to that performance?

Balchem Corporation reported Q2 2026 revenue of $284.0 million, representing an 11.2% increase year-over-year; the Human Nutrition and Health segment was the key driver, contributing $176.9 million in revenue with 10.0% growth.

How did Balchem's adjusted earnings per share in Q2 2026 compare to analyst expectations, and what was the market's immediate reaction to the earnings release?

Balchem's adjusted earnings per share for Q2 2026 were $1.49, which beat analyst estimates; despite this positive financial performance, the stock experienced a muted market reaction, though analysts generally maintained a constructive view.

Balchem Q2 2026: Revenue Hits $284.0M, Up 11% Year-Over-Year

Jul 31, 2026

Balchem Corporation reported Q2 2026 revenue of $284.0 million, an 11% increase driven by its Human Nutrition and Health segment. Adjusted earnings of $1.49 per share beat estimates, though the stock reaction remained muted.

AlphaStreet

2026-07-17

Balchem Corporation to announce Q2FY26 results on July 31

2026-07-23

Balchem Earnings Up Next: Can Specialty Ingredients Sustain Growth?

2026-07-27

Balchem (BCPC) Q2 2026 Preview: EPS Est. $1.43, Reports July 31

2026-07-31

Balchem Corporation Posts Q2 Adjusted EPS of $1.49, Surpassing Estimates

2026-07-31

Balchem Corporation Reports Second Quarter 2026 Financial Results